O36.0931 Maternal care for other rhesus isoimmunization, third trimester, fetus 1

Name of the Condition

• Maternal care for other rhesus isoimmunization, third trimester, fetus 1
• ICD Code: O36.0931

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the third trimester who has developed antibodies against the Rh factor, excluding anti-D antibodies, for a singleton pregnancy. The care focuses on managing potential risks to the fetus and ensuring maternal health, particularly when other Rh antibodies are present in late pregnancy.

Causes

Rhesus isoimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal blood, typically during a previous pregnancy or delivery. This exposure triggers the mother's immune system to produce antibodies that can cross the placenta and attack the red blood cells of an Rh-positive fetus in subsequent pregnancies. In this case, the antibodies are not anti-D but other Rh-specific antibodies.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., amniocentesis)
• Prior miscarriage or ectopic pregnancy involving an Rh-positive fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn

Diagnosis

Blood typing and antibody screening to detect non-anti-D Rh antibodies. Doppler ultrasound to assess fetal blood flow and anemia. Fetal blood sampling may be performed to evaluate hemoglobin levels and bilirubin.

Treatment Options

• Close monitoring of fetal well-being through ultrasound and non-stress tests
• Administration of intravenous immunoglobulin (IVIG) to reduce antibody levels
• Intrauterine blood transfusions if fetal anemia is severe
• Delivery planning based on fetal maturity and condition

Prognosis and Follow-Up

Prognosis depends on the severity of fetal anemia and the effectiveness of interventions. Regular follow-up with obstetric care is essential to monitor fetal status and adjust treatment as needed. Post-delivery care for the newborn may include phototherapy or exchange transfusion for jaundice.

Complications

• Severe fetal anemia leading to hydrops fetalis
• Preterm birth
• Neonatal jaundice requiring treatment
• Potential long-term neurological effects if untreated

Lifestyle & Prevention

• Rh-negative women should receive Rh immune globulin (RhIg) after any event that may cause fetal-maternal blood mixing, unless the father is also Rh-negative.
• Avoid unnecessary invasive procedures during pregnancy when possible.
• Follow prenatal care guidelines to detect and manage Rh incompatibility early.

When to Seek Professional Help

Seek immediate medical attention if experiencing abdominal pain, vaginal bleeding, or reduced fetal movement. Regular prenatal visits are critical for monitoring and early intervention.

Tips for Medical Coders

Document the trimester (third) and number of fetuses (singleton) to support the code O36.0931. Include details of antibody type (non-anti-D), monitoring frequency, and any interventions performed. Ensure documentation aligns with the specificity of the code for accurate reporting.